Log In
BCIQ
Print this Print this
 

TA-102

  Manage Alerts
Collapse Summary General Information
Company Actus Biotechnologies Inc.
DescriptionTopical formulation of tacrolimus
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacrocycle
Latest Stage of DevelopmentPreclinical
Standard IndicationDermatitis
Indication DetailsTreat atopic dermatitis (eczema)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today